SELLAS Life Sciences Group (SLS) Gains from Investment Securities: 2011-2024
Historic Gains from Investment Securities for SELLAS Life Sciences Group (SLS) over the last 7 years, with Dec 2024 value amounting to $526,000.
- SELLAS Life Sciences Group's Gains from Investment Securities was N/A to $368,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $526,000 for FY2024, which is 42.93% up from last year.
- Latest data reveals that SELLAS Life Sciences Group reported Gains from Investment Securities of $526,000 as of FY2024, which was up 42.93% from $368,000 recorded in FY2023.
- SELLAS Life Sciences Group's 5-year Gains from Investment Securities high stood at $976,000 for FY2020, and its period low was $368,000 during FY2023.
- Its 3-year average for Gains from Investment Securities is $447,667, with a median of $449,000 in 2022.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 77.78% in 2020, then declined by 18.04% in 2023.
- Over the past 4 years, SELLAS Life Sciences Group's Gains from Investment Securities (Yearly) stood at $976,000 in 2020, then reached $449,000 in 2022, then declined by 18.04% to $368,000 in 2023, then skyrocketed by 42.93% to $526,000 in 2024.